News & Updates

Prophylactic percutaneous endoscopic gastrostomy (pPEG) can enhance nutrition outcomes, reduce treatment delay, and maintain quality of life (QoL) in patients with head and neck cancer (HNC), suggests a recent study.

The inaugural European Society of Cardiology (ESC) Guideline on cardio-oncology, revealed at the ESC Congress 2022 in Barcelona, Spain, provides some much-needed information on the concurrent management of cancer and cardiovascular (CV) disease.

Thyroid cancer survivors experience a heightened risk of developing coronary heart disease (CHD) in the long term, a recent study has found.

First-line immunotherapy treatment with atezolizumab – a PD-L1 inhibitor – offers a survival advantage over single-agent chemotherapy in patients with advanced non-small cell lung cancer (NSCLC) who are ineligible for platinum doublets in the phase III IPSOS trial.

Tumour-infiltrating lymphocyte therapy significantly improved progression-free survival (PFS) in patients with advanced melanoma compared with standard-of-care treatment with ipilimumab, according to the M14TIL trial presented at ESMO 2022.